560 related articles for article (PubMed ID: 29800607)
21. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
Meng E; Hsu YC; Chuang YC
Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.
Scarneciu I; Bungau S; Lupu AM; Scarneciu CC; Bratu OG; Martha O; Tit DM; Aleya L; Lupu S
Eur J Pharm Sci; 2019 Nov; 139():105067. PubMed ID: 31499170
[TBL] [Abstract][Full Text] [Related]
23. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis.
Rooney P; Srivastava A; Watson L; Quinlan LR; Pandit A
Acta Biomater; 2015 Jun; 19():66-75. PubMed ID: 25818949
[TBL] [Abstract][Full Text] [Related]
25. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
Kuo HC
Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
[TBL] [Abstract][Full Text] [Related]
26. Si-Ni-San Ameliorates the Clinical Symptoms of Interstitial Cystitis/Bladder Pain Syndrome in Rats by Decreasing the Expression of Inflammatory Factors.
Yang Y; Shi Z; Yu H; Liu M; Hu T; Han C
Arch Esp Urol; 2023 Jul; 76(5):347-356. PubMed ID: 37545154
[TBL] [Abstract][Full Text] [Related]
27. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
28. Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.
Jhang JF
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31689912
[TBL] [Abstract][Full Text] [Related]
29. Role of Bladder Hydrodistention and Intravesical Sodium Hyaluronate in the Treatment of Interstitial Cystitis.
Yang JY; Wei W; Lan YL; Liu JQ; Wang HB; Li S
Urol J; 2015 Dec; 12(6):2417-21. PubMed ID: 26706738
[TBL] [Abstract][Full Text] [Related]
30. Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying Pathophysiology.
Liu HT; Jiang YH; Kuo HC
Low Urin Tract Symptoms; 2015 May; 7(2):102-7. PubMed ID: 26663690
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome.
Riedl CR; Engelhardt PF; Daha KL; Morakis N; Pflüger H
Int Urogynecol J Pelvic Floor Dysfunct; 2008 May; 19(5):717-21. PubMed ID: 18097627
[TBL] [Abstract][Full Text] [Related]
32. In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis.
Smith N; Saunders D; Lerner M; Zalles M; Mamedova N; Cheong D; Mohammadi E; Yuan T; Luo Y; Hurst RE; Greenwood-Van Meerveld B; Towner RA
PLoS One; 2020; 15(10):e0239282. PubMed ID: 33095778
[TBL] [Abstract][Full Text] [Related]
33. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
34. Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis.
de Oliveira MG; Mónica FZ; Calmasini FB; Alexandre EC; Tavares EBG; Soares AG; Costa SKP; Antunes E
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F460-F468. PubMed ID: 29717937
[TBL] [Abstract][Full Text] [Related]
35. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
36. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
Liu BK; Jin XW; Lu HZ; Zhang X; Zhao ZH; Shao Y
Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
[TBL] [Abstract][Full Text] [Related]
37. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
[TBL] [Abstract][Full Text] [Related]
38. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.
Gao Y; Liao L
Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160
[TBL] [Abstract][Full Text] [Related]
39. Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.
Boucher WS; Letourneau R; Huang M; Kempuraj D; Green M; Sant GR; Theoharides TC
J Urol; 2002 Jan; 167(1):380-4. PubMed ID: 11743360
[TBL] [Abstract][Full Text] [Related]
40. Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome.
Jensen MM; Jia W; Schults AJ; Isaacson KJ; Steinhauff D; Green B; Zachary B; Cappello J; Ghandehari H; Oottamasathien S
Biomaterials; 2019 Oct; 217():119293. PubMed ID: 31276948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
